Agreements

29th October, 2026 To, To, The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange (NSE), Phiroze Jheejheebhoy Towers, Exchange Plaza, Dalal Street, 5th Floor Plot No.C/1, 'G' Block Mumbai - 400 001. Bandra - Kurla Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS Dear Sir/ Madam Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Agreement to acquire 51% Equity Stake in Sarvottam Health Care Private Limited (Kakinada) Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and pursuant to the resolution adopted by the board of directors of Krishna Institute of Medical Sciences Limited (Company/ KIMS) wherein the Board of Directors had approved the proposal for acquisition of up to 51% of the total paid-up equity share capital of Sarvottam Health Care Private Limited, Kakinada, an O&M entity, for an aggregate consideration of up to ₹80.00 crore, today the Company has entered into definitive agreements in connection with the proposed acquisition and has remitted the consideration towards the acquisition. The transfer of the shares in favour of the Company is expected to be completed in due course. We enclose herewith the details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 as an Annexure-1 to this letter. Kindly take the above intimation on your records. This intimation is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE -1 a Name of the target entity, details in brief Name of the target entity: Sarvottam Health care such as size, turnover, etc., Private Limited. Details in brief: Sarvottam Health Care Private Limited (Target Company) commenced operations in 2010 with an initial capacity of 50 beds under the brand name “Trust Multi Speciality Hospital”, with a present capacity of 183 beds focusing on providing quality healthcare services to the Kakinada region. Recognizing the growing demand for advanced medical care in East Godavari district, the management invested in constructing a new state-of-the-art hospital campus. In 2021, hospital inaugurated a state of art hospital building comprising of a cellar + ground floor with 7 upper floors (G+7 structure), with a total built-up area of approximately 9847.23 square mtrs on a company owned land ad measuring 3001 .36 Sq Yards and commissioned additional 183 beds. This makes Trust Hospitals as one of the largest and most comprehensive healthcare providers in Kakinada. (Rs. in Crore) FY 2025-26 Turnover: 84.83 PAT: 7.06 Networth: 50.30 b Whether the acquisition would fall within Acquisition of equity shares does not fall within related party transaction(s) and whether the definition of Related Party Transaction. the promoter / promoter group / group However the Company has entered into Operation and Management agreement dated 10th September, companies have any interest in the entity 2026 with the target entity. The O&M services are being acquired? If yes, nature of Interest provided on Arms Length basis to the said entity and details thereof and whether the same is done at "Arms length": c Industry to which the entity being acquired Healthcare Industry belongs: d Objects and effects of acquisition (including KIMS being the O & M service provider and by but not limited to, disclosure of reasons for virtue of call option agreement of the target entity acquisition of target entity, if its business is has acquired 51% of the total equity stake as a strategic investment. outside the main line of business of the listed entity e Brief details of any governmental or regulatory Not Applicable. approvals required for the acquisition: f Indicative time period for completion of the Not Applicable acquisition g Consideration - whether cash consideration Cash. or share swap and details of the same: h Cost of acquisition or the price at which the The shares are acquired based on the valuation shares are acquired; report issued by BDO Valuation Advisory LLP dated 05th October, 2026, for an aggregate consideration up to ₹79.50 Crore (Rupees Seventy Nine Crore Fifty Lakhs only). i Percentage of shareholding/control KIMS has acquired 21,72,713 equity shares of Rs. acquired and/or number of shares 10 each representing 51.00% of the equity share acquired; capital of Target Company, for an aggregate consideration of up to ₹79.50 Crore (Rupees Seventy Nine Crore Fifty Lakhs only). The Shares will be transferred in due course. j Brief background about the entity acquired Brief background about the entity acquired: As in terms of products/line of business mentioned in serial no. (a) acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence, and any other Date of Incorporation: 19-04-2011 significant information (in brief): History of last 3 years Total Turnover of the Company: Particulars Amount in Crores FY26 84.83 FY25 81.38 FY24 74.36 Presence: Kakinada, Andhra Pradesh - India Other Significant Information: please refer to the aforementioned.